58 Hvtn PPTs View free & download

Reshaping the Scientific Agenda of the HVTN PowerPoint PPT Presentation

Reshaping the Scientific Agenda of the HVTN - ... process between human and nonhuman primate studies that should allow the field ... Nonhuman primates. Efficacy. Biological and behavioral cofactors ...

... process between human and nonhuman primate studies that should allow the field ... Nonhuman primates. Efficacy. Biological and behavioral cofactors ...

| PowerPoint PPT presentation | free to download

The HVTN Experience with Modified Vaccinia Ankara PowerPoint PPT Presentation

The HVTN Experience with Modified Vaccinia Ankara - Modified Vaccinia Ankara is a highly attenuated vaccinia ... SCHARP: Gina Escamilla, Huguette Redinger, Diana Lynn, Ya-Lin Chiu, Alicia Sato, ...

Modified Vaccinia Ankara is a highly attenuated vaccinia ... SCHARP: Gina Escamilla, Huguette Redinger, Diana Lynn, Ya-Lin Chiu, Alicia Sato, ...

| PowerPoint PPT presentation | free to view

Host genetics of T cell responses and Ad5 titers in the STEP trial A CHAVI HVTN collaboration PowerPoint PPT Presentation

Host genetics of T cell responses and Ad5 titers in the STEP trial A CHAVI HVTN collaboration - HLA Class I: high-resolution typing using sequence-based methods ... that they explain most of the association signals detected in the SNP scan ...

HLA Class I: high-resolution typing using sequence-based methods ... that they explain most of the association signals detected in the SNP scan ...

| PowerPoint PPT presentation | free to view

Detection of Merck Ad5 Vaccine Vector and HIV-1 Insert Genes in HVTN 071: a Trial Using the MRKAd5 gag/pol/nef Vaccine from the Step Study PowerPoint PPT Presentation

Detection of Merck Ad5 Vaccine Vector and HIV-1 Insert Genes in HVTN 071: a Trial Using the MRKAd5 gag/pol/nef Vaccine from the Step Study - To develop a new ultrasensitive PCR assay capable of detecting extremely low ... The Zhu lab previously used a sensitive limiting-dilution nested PCR to detect ...

To develop a new ultrasensitive PCR assay capable of detecting extremely low ... The Zhu lab previously used a sensitive limiting-dilution nested PCR to detect ...

| PowerPoint PPT presentation | free to download

On Surrogate Endpoints in HIV Vaccine Efficacy Trials PowerPoint PPT Presentation

On Surrogate Endpoints in HIV Vaccine Efficacy Trials - Title: HVTN Efficacy Trials: Overview Author: Steve Self Last modified by: Tara Stull Created Date: 12/17/2002 9:33:16 PM Document presentation format

Title: HVTN Efficacy Trials: Overview Author: Steve Self Last modified by: Tara Stull Created Date: 12/17/2002 9:33:16 PM Document presentation format

| PowerPoint PPT presentation | free to view

SAAVI VTN - Non-human primate challenge studies. GLP-compliant regulatory studies. Clinical Trials ... Experiments in rodents and primates. Human trials. Safety, immunogenicity ...

Non-human primate challenge studies. GLP-compliant regulatory studies. Clinical Trials ... Experiments in rodents and primates. Human trials. Safety, immunogenicity ...

| PowerPoint PPT presentation | free to view

Follow-on Trials Based on RV144: Strategy includes development and research tracks PowerPoint PPT Presentation

Follow-on Trials Based on RV144: Strategy includes development and research tracks - P5 partners include the US NIAID, the Bill & Melinda Gates Foundation, the HIV Vaccine Trials Network, the US Military HIV Research Program, ...

P5 partners include the US NIAID, the Bill & Melinda Gates Foundation, the HIV Vaccine Trials Network, the US Military HIV Research Program, ...

| PowerPoint PPT presentation | free to download

HIV Prevention Research: DAIDS and the New Clinical Research Trial Networks PowerPoint PPT Presentation

HIV Prevention Research: DAIDS and the New Clinical Research Trial Networks - Create a consortium of linked trial networks. Coordinate activities across a ... Dar es Salaam, Tanzania, South Africa, Kampala, Uganda, Chitungwiza,Zimbabwe ...

Create a consortium of linked trial networks. Coordinate activities across a ... Dar es Salaam, Tanzania, South Africa, Kampala, Uganda, Chitungwiza,Zimbabwe ...

| PowerPoint PPT presentation | free to view

How to Apply for PIF PowerPoint PPT Presentation

How to Apply for PIF - Virology. NVP resistance. Simpler, cheaper diagnostics for ... PK, virology, genomics, immunology. Neutralizing antibody assays- breast milk may be a problem ...

Virology. NVP resistance. Simpler, cheaper diagnostics for ... PK, virology, genomics, immunology. Neutralizing antibody assays- breast milk may be a problem ...

| PowerPoint PPT presentation | free to view

SCHARP Visit Scheduler Tool (VST) - SCHARP Visit Scheduler Tool VST

SCHARP Visit Scheduler Tool VST

| PowerPoint PPT presentation | free to download

Update on the STEP Study Merck V520 Protocol 023HVTN 502 PowerPoint PPT Presentation

Update on the STEP Study Merck V520 Protocol 023HVTN 502 - Michael N. Robertson, Susan Buchbinder, Dan Fitzgerald, Ann Duerr, and Dale Lawrence ... Drug overdose. Gun shot wound. Based on available AE data as of 30-Sep-2006 ...

Michael N. Robertson, Susan Buchbinder, Dan Fitzgerald, Ann Duerr, and Dale Lawrence ... Drug overdose. Gun shot wound. Based on available AE data as of 30-Sep-2006 ...

| PowerPoint PPT presentation | free to view

A Biometric Approach to Vaccine Insert Design PowerPoint PPT Presentation

A Biometric Approach to Vaccine Insert Design - How many of these are present in a virus sampled randomly from a target viral population? ... For Subtypes A and C viral populations, ...

How many of these are present in a virus sampled randomly from a target viral population? ... For Subtypes A and C viral populations, ...

| PowerPoint PPT presentation | free to download

Kinetics of T cell responses to vaccination for HIV with heterologous DNA prime-rAd5 boost contrasted with homologous rAd5 prime-boost PowerPoint PPT Presentation

Kinetics of T cell responses to vaccination for HIV with heterologous DNA prime-rAd5 boost contrasted with homologous rAd5 prime-boost - Cytokine and memory marker distribution of induced T cell responses ... Global potential T cell epitope (PTE) peptide pools for Env, Gag, Pol and Nef ...

Cytokine and memory marker distribution of induced T cell responses ... Global potential T cell epitope (PTE) peptide pools for Env, Gag, Pol and Nef ...

| PowerPoint PPT presentation | free to download

PAVE Executive Group Meeting Site Development Working Group Results of Webbased Survey PowerPoint PPT Presentation

PAVE Executive Group Meeting Site Development Working Group Results of Webbased Survey - DAIDS Sachs (L), Lehrman, Matula, McNeil, Reese, Reynolds. SDWG Objectives ... Create database to profile the capacity of sites to conduct phase IIB/III trials ...

DAIDS Sachs (L), Lehrman, Matula, McNeil, Reese, Reynolds. SDWG Objectives ... Create database to profile the capacity of sites to conduct phase IIB/III trials ...

| PowerPoint PPT presentation | free to view

Established in late 1999 PowerPoint PPT Presentation

Established in late 1999 - Immunology. assessment. Human. Animal. What do we expect from an HIV vaccine? 'Viral load' in HIV ... State Vaccine Institute. Strategic national. alliances. TT - 2002 ...

Immunology. assessment. Human. Animal. What do we expect from an HIV vaccine? 'Viral load' in HIV ... State Vaccine Institute. Strategic national. alliances. TT - 2002 ...

| PowerPoint PPT presentation | free to download

An AIDS vaccine: challenges and progress PowerPoint PPT Presentation

An AIDS vaccine: challenges and progress - Christine White-Ziegler Kahn Institute Fellow, Biotechnology and World Health

Christine White-Ziegler Kahn Institute Fellow, Biotechnology and World Health

| PowerPoint PPT presentation | free to download

What is Community Partners PowerPoint PPT Presentation

What is Community Partners - HIV Prevention Trials Network (HPTN) International Maternal Pediatric ... International Network for Strategic Initiatives in Global HIV Trials (INSIGHT) ...

HIV Prevention Trials Network (HPTN) International Maternal Pediatric ... International Network for Strategic Initiatives in Global HIV Trials (INSIGHT) ...

| PowerPoint PPT presentation | free to view

Ethical Issues in HIV Vaccine Trials : An Ethical Case Study and Community Responses' Is this a conc PowerPoint PPT Presentation

Ethical Issues in HIV Vaccine Trials : An Ethical Case Study and Community Responses' Is this a conc - Ethical Issues in HIV Vaccine Trials : An Ethical Case Study and Community Responses. ... Ethical behaviors relative to study participants ...

Ethical Issues in HIV Vaccine Trials : An Ethical Case Study and Community Responses. ... Ethical behaviors relative to study participants ...

| PowerPoint PPT presentation | free to view

McIntyre CROI 2005 PowerPoint PPT Presentation

McIntyre CROI 2005 - Phase IIB HIV Vaccine Trials & viral load endpoints: looking for efficacy. Glenda Gray ... Features of a Phase IIB 'Test of Concept' HIV Vaccine Trial ...

Phase IIB HIV Vaccine Trials & viral load endpoints: looking for efficacy. Glenda Gray ... Features of a Phase IIB 'Test of Concept' HIV Vaccine Trial ...

| PowerPoint PPT presentation | free to view

Adult AIDS Clinical Trials Group International Therapeutic Initiative PowerPoint PPT Presentation

Adult AIDS Clinical Trials Group International Therapeutic Initiative - ... International Therapeutic Clinical Trials Initiative ... Pharma-independent sources of ARVs are needed for clinical trials in resource-limited settings ...

... International Therapeutic Clinical Trials Initiative ... Pharma-independent sources of ARVs are needed for clinical trials in resource-limited settings ...

| PowerPoint PPT presentation | free to view

Global Prevention and Treatment of Pediatric HIV-1 Infection PowerPoint PPT Presentation

Global Prevention and Treatment of Pediatric HIV-1 Infection - UMMS. Pediatric HIV/AIDS: 2005. 2.5 million infants at risk for MTCT. ... Industrialized countries: ART have markedly decreased MTCT and pediatric HIV ...

UMMS. Pediatric HIV/AIDS: 2005. 2.5 million infants at risk for MTCT. ... Industrialized countries: ART have markedly decreased MTCT and pediatric HIV ...

| PowerPoint PPT presentation | free to view

Novel Approaches to Augmenting the Immunogenicity of DNA Vaccines for HIV1 Dan H. Barouch March 18, PowerPoint PPT Presentation

Novel Approaches to Augmenting the Immunogenicity of DNA Vaccines for HIV1 Dan H. Barouch March 18, - Novel Approaches to Augmenting the Immunogenicity of DNA Vaccines ... Group N (vac/ctrl) DNA Vaccine Plasmid IL-2/Ig. A 5 / 6 4 mg 0.1 mg. B 5 / 6 4 mg 0.5 mg ...

Novel Approaches to Augmenting the Immunogenicity of DNA Vaccines ... Group N (vac/ctrl) DNA Vaccine Plasmid IL-2/Ig. A 5 / 6 4 mg 0.1 mg. B 5 / 6 4 mg 0.5 mg ...

| PowerPoint PPT presentation | free to view

MTN 003 Data Management Considerations PowerPoint PPT Presentation

MTN 003 Data Management Considerations - Title: Quality Control Reports Author: scharp user Last modified by: lmckinst Created Date: 4/20/2004 10:22:22 PM Document presentation format: On-screen Show

Title: Quality Control Reports Author: scharp user Last modified by: lmckinst Created Date: 4/20/2004 10:22:22 PM Document presentation format: On-screen Show

| PowerPoint PPT presentation | free to download

Slide sem t - Title: Slide sem t tulo Author: Ind strias Romi S.A. Last modified by: IEP Created Date: 5/22/2001 6:31:52 AM Document presentation format: Apresenta o na tela

Title: Slide sem t tulo Author: Ind strias Romi S.A. Last modified by: IEP Created Date: 5/22/2001 6:31:52 AM Document presentation format: Apresenta o na tela

| PowerPoint PPT presentation | free to view

AN HIV Vaccine Trial in the Caribbean: The Haiti Site Experience PowerPoint PPT Presentation

AN HIV Vaccine Trial in the Caribbean: The Haiti Site Experience - HIV Vaccine trials are a very sensitive topic worldwide, with a high level of ... The consent form has been translated into Creole ...

HIV Vaccine trials are a very sensitive topic worldwide, with a high level of ... The consent form has been translated into Creole ...

| PowerPoint PPT presentation | free to view

HIV Vaccine Development: Cautious Optimism about a Formidable Foe PowerPoint PPT Presentation

HIV Vaccine Development: Cautious Optimism about a Formidable Foe - HIV Vaccine Development: Cautious Optimism about a Formidable Foe Why Has It Been So Diffficult? We know more about the molecular biology mechanism of attachment and ...

HIV Vaccine Development: Cautious Optimism about a Formidable Foe Why Has It Been So Diffficult? We know more about the molecular biology mechanism of attachment and ...

| PowerPoint PPT presentation | free to view

CFAR Social and Behavioral Sciences Research Network SBSRN 1st Scientific Meeting Summary Philadelph PowerPoint PPT Presentation

CFAR Social and Behavioral Sciences Research Network SBSRN 1st Scientific Meeting Summary Philadelph - Case Western Reserve University/University Hospitals of Cleveland. Duke University ... New York University College of Medicine. University of Alabama at Birmingham ...

Case Western Reserve University/University Hospitals of Cleveland. Duke University ... New York University College of Medicine. University of Alabama at Birmingham ...

| PowerPoint PPT presentation | free to view

Neutralizing Antibody Assays for HIV-1, SIV and SHIV: Recent Advances in Technology PowerPoint PPT Presentation

Neutralizing Antibody Assays for HIV-1, SIV and SHIV: Recent Advances in Technology - ... vaginal, rectal and oral routes of challenge in nonhuman primates. ... Primate Core Immunology Laboratory for AIDS Vaccine Research and Development (PCIL) ...

... vaginal, rectal and oral routes of challenge in nonhuman primates. ... Primate Core Immunology Laboratory for AIDS Vaccine Research and Development (PCIL) ...

| PowerPoint PPT presentation | free to view

Construction of a CD8 T cell epitope knockout live attenuated SIV vaccine for Mauritian cynomolgus m PowerPoint PPT Presentation

Construction of a CD8 T cell epitope knockout live attenuated SIV vaccine for Mauritian cynomolgus m - Support for David O'Connor's lab: NIH NIAID. NIH NCRR. International AIDS Vaccine Initiative ... Charles River Laboratories. David O'Connor. Esper Kallas ...

Support for David O'Connor's lab: NIH NIAID. NIH NCRR. International AIDS Vaccine Initiative ... Charles River Laboratories. David O'Connor. Esper Kallas ...

| PowerPoint PPT presentation | free to view

On Surrogate Endpoints in HIV Vaccine Efficacy Trials - On Surrogate Endpoints in HIV Vaccine Efficacy Trials

On Surrogate Endpoints in HIV Vaccine Efficacy Trials

| PowerPoint PPT presentation | free to view

Vaccine Effects on HIV1 Progression in the Step Study PowerPoint PPT Presentation

Vaccine Effects on HIV1 Progression in the Step Study - SCHARP/Fred Hutchinson Cancer Research Center. 2. Study Team. SCHARP/FHCRC. Peter Gilbert ... No Difference Between Treatment Groups in Time to Study Dropout ...

SCHARP/Fred Hutchinson Cancer Research Center. 2. Study Team. SCHARP/FHCRC. Peter Gilbert ... No Difference Between Treatment Groups in Time to Study Dropout ...

| PowerPoint PPT presentation | free to download

HIV Prevention Research: Where and How for Communities PowerPoint PPT Presentation

HIV Prevention Research: Where and How for Communities - US government sponsored HIV prevention research is in a time of flux ... Source: http://grants1.nih.gove/grants/guide/rfa-files/RFA-AI-05-001.html 'Old' DAIDS Networks ...

US government sponsored HIV prevention research is in a time of flux ... Source: http://grants1.nih.gove/grants/guide/rfa-files/RFA-AI-05-001.html 'Old' DAIDS Networks ...

| PowerPoint PPT presentation | free to view

ATAC CCG TeachIn PowerPoint PPT Presentation

ATAC CCG TeachIn - President Ronald Reagan didn't mention the word 'AIDS' until 1987. ... Communicate your goals & accomplishments. Build sustainable movements. ...

President Ronald Reagan didn't mention the word 'AIDS' until 1987. ... Communicate your goals & accomplishments. Build sustainable movements. ...

| PowerPoint PPT presentation | free to view

Overview and Research Priorities of the Division of AIDS DAIDS 4th IAS Conference on HIV Pathogenesi PowerPoint PPT Presentation

Overview and Research Priorities of the Division of AIDS DAIDS 4th IAS Conference on HIV Pathogenesi - Integrated Preclinical/Clinical AIDS Vaccine Development Program (IPACVD) (1997) ... Center for HIV/AIDS Vaccine Immunology (CHAVI) (2005) ...

Integrated Preclinical/Clinical AIDS Vaccine Development Program (IPACVD) (1997) ... Center for HIV/AIDS Vaccine Immunology (CHAVI) (2005) ...

| PowerPoint PPT presentation | free to view

Preventive HIV Vaccines at the Crossroads PowerPoint PPT Presentation

Preventive HIV Vaccines at the Crossroads - The International AIDS Society USA. SM Hammer, MD. ... Pertussis. Streptococcus gordonii. Saccharomyces. Aspergillus. Viral. Bacterial. Fungal ...

The International AIDS Society USA. SM Hammer, MD. ... Pertussis. Streptococcus gordonii. Saccharomyces. Aspergillus. Viral. Bacterial. Fungal ...

| PowerPoint PPT presentation | free to view

AIDS Clinical Trials Group ACTG Network: Research Agenda PowerPoint PPT Presentation

AIDS Clinical Trials Group ACTG Network: Research Agenda - Translational research and new drug development (25% effort) Vaccine research (therapeutic vaccines 5-10% effort) ... Phase I/II: PK and drug interaction studies ...

Translational research and new drug development (25% effort) Vaccine research (therapeutic vaccines 5-10% effort) ... Phase I/II: PK and drug interaction studies ...

| PowerPoint PPT presentation | free to view

Lessons Learned from the Step Study PowerPoint PPT Presentation

Lessons Learned from the Step Study - Vaccine: 1:1:1 admixture of 3 Ad5 vectors ... Peter Gilbert. Tirzah Griffin. Soyon Im. Dale Lawrence. Rosario Leon. David Li. Ellen MacLachlan ...

Vaccine: 1:1:1 admixture of 3 Ad5 vectors ... Peter Gilbert. Tirzah Griffin. Soyon Im. Dale Lawrence. Rosario Leon. David Li. Ellen MacLachlan ...

| PowerPoint PPT presentation | free to view

IMPAACT Community Perspective on Scientific Agenda PowerPoint PPT Presentation

IMPAACT Community Perspective on Scientific Agenda - The Mission of the ICAB is to improve the value of clinical research ... ICAB Representative: Samantha Kuryla. Top Priorities. Simpler treatment regimens, including ...

The Mission of the ICAB is to improve the value of clinical research ... ICAB Representative: Samantha Kuryla. Top Priorities. Simpler treatment regimens, including ...

| PowerPoint PPT presentation | free to view

EpitopeSpecific Responses in Non Human Primates and The Relationship to Protection from NHP Challeng PowerPoint PPT Presentation

EpitopeSpecific Responses in Non Human Primates and The Relationship to Protection from NHP Challeng - Quote from an eminent HIV vaccine researcher at the AVRS meeting on 12/12/07. Goal: ... We have not tested the T cell vaccine concept yet. ...

Quote from an eminent HIV vaccine researcher at the AVRS meeting on 12/12/07. Goal: ... We have not tested the T cell vaccine concept yet. ...

| PowerPoint PPT presentation | free to view

The HIV Prevention Trials Network HPTN and the International Maternal Pediatric Adolescent AIDS Clin PowerPoint PPT Presentation

The HIV Prevention Trials Network HPTN and the International Maternal Pediatric Adolescent AIDS Clin - Black men who have sex with men. Low frequency. of HIV testing, High proportion. unaware of status, ... Atlanta 27,923. Baltimore 46,438. Boston 7,234. Los ...

Black men who have sex with men. Low frequency. of HIV testing, High proportion. unaware of status, ... Atlanta 27,923. Baltimore 46,438. Boston 7,234. Los ...

| PowerPoint PPT presentation | free to view

Update: HIV Vaccines and other Prevention Research PowerPoint PPT Presentation

Update: HIV Vaccines and other Prevention Research - Duration between discovery of cause of infectious diseases and ... Pertussis. 92. Haemophilus influenzae. 105. Typhoid. Years to develop vaccine. Disease ...

Duration between discovery of cause of infectious diseases and ... Pertussis. 92. Haemophilus influenzae. 105. Typhoid. Years to develop vaccine. Disease ...

| PowerPoint PPT presentation | free to view

Sieve analysis of the Step trial: Evidence for vaccineinduced antigenic pressure on HIV PowerPoint PPT Presentation

Sieve analysis of the Step trial: Evidence for vaccineinduced antigenic pressure on HIV - But at the moment we only have one time-point per subject. 4 ... NetMHC predicts CTL epitopes based on experimental binding affinity of peptides ...

But at the moment we only have one time-point per subject. 4 ... NetMHC predicts CTL epitopes based on experimental binding affinity of peptides ...

| PowerPoint PPT presentation | free to download

La Prevencin del VIHSIDA PowerPoint PPT Presentation

La Prevencin del VIHSIDA - ... DE ENSAYOS CLINICOS. Eficacia de Condones. A pesar de los sesgos hacia efecto nulo (ej. Prejuicio social, uso selectivo de condones con parejas de alto riesgo, ...

... DE ENSAYOS CLINICOS. Eficacia de Condones. A pesar de los sesgos hacia efecto nulo (ej. Prejuicio social, uso selectivo de condones con parejas de alto riesgo, ...

| PowerPoint PPT presentation | free to view

UL TEAM MEMBERS Prof M Nchabeleng and Micro team Microbiology Prof MO Mzelini and Internal Medicine PowerPoint PPT Presentation

UL TEAM MEMBERS Prof M Nchabeleng and Micro team Microbiology Prof MO Mzelini and Internal Medicine - Clinicians from Internal Medicine, Paediatrics, and Obstetrics and Gynaecology ... Conducted Phases 1 to III trials on microbicide Carraguard gel ...

Clinicians from Internal Medicine, Paediatrics, and Obstetrics and Gynaecology ... Conducted Phases 1 to III trials on microbicide Carraguard gel ...

| PowerPoint PPT presentation | free to view

precedence - clinical trials should go ahead of, be prioritized relative to, basic research ... I (A*01) delay simian immunodeficiency virus SIVmac-induced immunodeficiency. ...

clinical trials should go ahead of, be prioritized relative to, basic research ... I (A*01) delay simian immunodeficiency virus SIVmac-induced immunodeficiency. ...

| PowerPoint PPT presentation | free to download

Database Text Searching using Triggers, TSearch2, Materialized Views and User Security PowerPoint PPT Presentation

Database Text Searching using Triggers, TSearch2, Materialized Views and User Security - The Statistical Center for HIV/AIDS Research & Prevention (SCHARP) is part of ... SCHARP provides statistical collaboration to infectious disease researchers ...

The Statistical Center for HIV/AIDS Research & Prevention (SCHARP) is part of ... SCHARP provides statistical collaboration to infectious disease researchers ...

| PowerPoint PPT presentation | free to view

Viral Diversity Considerations for a PowerPoint PPT Presentation

Viral Diversity Considerations for a - Eventual AIDS Vaccine Failure by Viral Escape from CD8 T Lymphocytes in a Rhesus Monkey ... 20 rhesus monkeys immunized once with 3x1010 vp rAd26 vectors ...

Eventual AIDS Vaccine Failure by Viral Escape from CD8 T Lymphocytes in a Rhesus Monkey ... 20 rhesus monkeys immunized once with 3x1010 vp rAd26 vectors ...

| PowerPoint PPT presentation | free to view

The Big Picture PowerPoint PPT Presentation

The Big Picture - CCG- Community Constituency Group. CCWG- Cross-CAB ... PCCG- PACTG Community Constituency Group ... Community Constituency Group (CCG) formed with 22 members ...

CCG- Community Constituency Group. CCWG- Cross-CAB ... PCCG- PACTG Community Constituency Group ... Community Constituency Group (CCG) formed with 22 members ...

| PowerPoint PPT presentation | free to view

Promoting innovation through research networks: IAVI and our global partners PowerPoint PPT Presentation

Promoting innovation through research networks: IAVI and our global partners - IAVI Human Immunology Lab -Programs at Oxford, Scripps, DBT (India) ... Karolinska Institute, Sweden. Medical Research Council, UK. St. Georges, Uni of London, UK ...

IAVI Human Immunology Lab -Programs at Oxford, Scripps, DBT (India) ... Karolinska Institute, Sweden. Medical Research Council, UK. St. Georges, Uni of London, UK ...

| PowerPoint PPT presentation | free to view

FUTURE - Non-clinical toxicology has not identified any clear target organ ... UK-427,857 Pre-clinical Profile. Selective, reversible binding to the CCR5 receptor ...

Non-clinical toxicology has not identified any clear target organ ... UK-427,857 Pre-clinical Profile. Selective, reversible binding to the CCR5 receptor ...

| PowerPoint PPT presentation | free to view

WHOUNAIDSUNSW Satellite Session "Access to care and treatment in the context of HIV vaccine and othe PowerPoint PPT Presentation

WHOUNAIDSUNSW Satellite Session "Access to care and treatment in the context of HIV vaccine and othe - National AIDS Vaccine Plans and Strategies. Initiated in 1992 in Brazil, Thailand and Uganda. ... The African AIDS Vaccine Programme (AAVP) was launched in 2000 ...

National AIDS Vaccine Plans and Strategies. Initiated in 1992 in Brazil, Thailand and Uganda. ... The African AIDS Vaccine Programme (AAVP) was launched in 2000 ...

| PowerPoint PPT presentation | free to view

In thinking about vaccines, recall that there are two arms of the adaptive immune response PowerPoint PPT Presentation

In thinking about vaccines, recall that there are two arms of the adaptive immune response - In thinking about vaccines, recall that there are two arms of the adaptive immune response ... For most viruses, you are immune to reinfection by the same virus ...

In thinking about vaccines, recall that there are two arms of the adaptive immune response ... For most viruses, you are immune to reinfection by the same virus ...

| PowerPoint PPT presentation | free to view

Data Management PowerPoint PPT Presentation

Data Management - Medical History/Concomitant Disorders. Participant Compliance. Outcome Measurements ... Concomitant Medications. Behavioral (eg Quality of Life, compliance, diary) ...

Medical History/Concomitant Disorders. Participant Compliance. Outcome Measurements ... Concomitant Medications. Behavioral (eg Quality of Life, compliance, diary) ...

| PowerPoint PPT presentation | free to view

Mujer y VIH - Esta conferencia ha sido revisada en detalle para asegurar que no haya ... Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women ...

Esta conferencia ha sido revisada en detalle para asegurar que no haya ... Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women ...

| PowerPoint PPT presentation | free to view

Clinical Evaluation of Vaccines PowerPoint PPT Presentation

Clinical Evaluation of Vaccines - Clinical evaluation alone can involve a dozen interlocking trials of different ... Goal is to provide 'robust and compelling evidence' for net clinical benefit ...

Clinical evaluation alone can involve a dozen interlocking trials of different ... Goal is to provide 'robust and compelling evidence' for net clinical benefit ...

| PowerPoint PPT presentation | free to download

HSV2 is associated with HIV acquisition among both placebo PowerPoint PPT Presentation

HSV2 is associated with HIV acquisition among both placebo - Vaccine effect among circumcised. 0.016. 1.1-3.0. 1.8. Unprotected insertive anal sex ... Male circumcision (circumcised) P. Odds ratio (95% CI) Baseline risk factor ...

Vaccine effect among circumcised. 0.016. 1.1-3.0. 1.8. Unprotected insertive anal sex ... Male circumcision (circumcised) P. Odds ratio (95% CI) Baseline risk factor ...

| PowerPoint PPT presentation | free to view

Hvtn PowerPoint PPT Presentations